Cosmo Bio CompanyLimited Past Earnings Performance
Past criteria checks 2/6
Cosmo Bio CompanyLimited has been growing earnings at an average annual rate of 10.6%, while the Healthcare industry saw earnings growing at 6% annually. Revenues have been growing at an average rate of 6.3% per year. Cosmo Bio CompanyLimited's return on equity is 5.1%, and it has net margins of 4.7%.
Key information
10.6%
Earnings growth rate
11.0%
EPS growth rate
| Healthcare Industry Growth | 7.9% |
| Revenue growth rate | 6.3% |
| Return on equity | 5.1% |
| Net Margin | 4.7% |
| Next Earnings Update | 09 May 2024 |
Recent past performance updates
Recent updates
Cosmo Bio CompanyLimited (TYO:3386) Is Experiencing Growth In Returns On Capital
May 09
Cosmo Bio Company,Limited (TYO:3386) Vies For A Place In Your Dividend Portfolio: Here's Why
Mar 23Cosmo Bio Company,Limited's (TYO:3386) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock?
Mar 02Will The ROCE Trend At Cosmo Bio CompanyLimited (TYO:3386) Continue?
Feb 07
Does Cosmo Bio CompanyLimited's (TYO:3386) Share Price Gain of 30% Match Its Business Performance?
Jan 17Should Cosmo Bio Company,Limited (TYO:3386) Be Part Of Your Dividend Portfolio?
Dec 23Do Fundamentals Have Any Role To Play In Driving Cosmo Bio Company,Limited's (TYO:3386) Stock Up Recently?
Dec 02Revenue & Expenses BreakdownBeta
How Cosmo Bio CompanyLimited makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Dec 23 | 9,340 | 442 | 2,729 | 0 |
| 30 Sep 23 | 9,303 | 429 | 2,753 | 0 |
| 30 Jun 23 | 9,269 | 471 | 2,677 | 0 |
| 31 Mar 23 | 9,334 | 415 | 2,681 | 0 |
| 31 Dec 22 | 9,553 | 517 | 2,624 | 0 |
| 30 Sep 22 | 9,477 | 576 | 2,647 | 0 |
| 30 Jun 22 | 9,507 | 654 | 2,637 | 0 |
| 31 Mar 22 | 9,400 | 770 | 2,597 | 0 |
| 31 Dec 21 | 9,231 | 737 | 2,609 | 0 |
| 30 Sep 21 | 9,147 | 714 | 2,579 | 0 |
| 30 Jun 21 | 8,981 | 714 | 2,526 | 0 |
| 31 Mar 21 | 8,550 | 775 | 2,406 | 0 |
| 31 Dec 20 | 8,092 | 674 | 2,399 | 0 |
| 30 Sep 20 | 7,821 | 553 | 2,343 | 0 |
| 30 Jun 20 | 7,742 | 508 | 2,352 | 0 |
| 31 Mar 20 | 7,862 | 322 | 2,477 | 0 |
| 31 Dec 19 | 7,590 | 237 | 2,474 | 0 |
| 30 Sep 19 | 7,499 | 317 | 2,415 | 0 |
| 30 Jun 19 | 7,257 | 256 | 2,394 | 0 |
| 31 Mar 19 | 7,113 | 230 | 2,339 | 0 |
| 31 Dec 18 | 7,261 | 260 | 2,330 | 0 |
| 30 Sep 18 | 7,189 | 171 | 2,335 | 0 |
| 30 Jun 18 | 7,167 | 156 | 2,343 | 0 |
| 31 Mar 18 | 7,159 | 270 | 2,347 | 0 |
| 31 Dec 17 | 7,068 | 237 | 2,339 | 0 |
| 30 Sep 17 | 7,027 | 217 | 2,354 | 0 |
| 30 Jun 17 | 7,143 | 261 | 2,339 | 0 |
| 31 Mar 17 | 7,309 | 190 | 2,315 | 0 |
| 31 Dec 16 | 7,427 | 254 | 2,257 | 0 |
| 30 Sep 16 | 7,559 | 363 | 2,231 | 0 |
| 30 Jun 16 | 7,507 | 342 | 2,189 | 0 |
| 31 Mar 16 | 7,351 | 286 | 2,163 | 0 |
| 31 Dec 15 | 7,357 | 230 | 2,180 | 0 |
| 30 Sep 15 | 7,424 | 190 | 2,164 | 0 |
| 30 Jun 15 | 7,394 | 163 | 2,205 | 0 |
| 31 Mar 15 | 7,371 | 201 | 2,228 | 0 |
| 31 Dec 14 | 7,235 | 201 | 2,261 | 0 |
| 30 Sep 14 | 7,112 | 203 | 2,277 | 0 |
| 30 Jun 14 | 7,167 | 310 | 2,302 | 0 |
| 31 Mar 14 | 7,149 | 297 | 2,317 | 0 |
| 31 Dec 13 | 7,050 | 313 | 2,349 | 0 |
| 30 Sep 13 | 7,116 | 332 | 2,433 | 0 |
| 30 Jun 13 | 7,105 | 324 | 2,409 | 0 |
Quality Earnings: 3386 has high quality earnings.
Growing Profit Margin: 3386's current net profit margins (4.7%) are lower than last year (5.4%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 3386's earnings have grown by 10.6% per year over the past 5 years.
Accelerating Growth: 3386's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Earnings vs Industry: 3386 had negative earnings growth (-14.5%) over the past year, making it difficult to compare to the Healthcare industry average (8.4%).
Return on Equity
High ROE: 3386's Return on Equity (5.1%) is considered low.